These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6135105)

  • 1. Prostaglandin E-1 and peripheral vascular disease.
    Kyle V; Hazleman B
    Lancet; 1983 Jul; 2(8344):282. PubMed ID: 6135105
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analogs of prostaglandin-related substances and inhibitors of their formation and metabolism. Clinical application to the surgical field].
    Mishima Y
    Nihon Rinsho; 1985 Mar; 43(3):598-602. PubMed ID: 3892091
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandins in therapy of cardiovascular disease.
    Szczeklik A; Gryglewski RJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():345-54. PubMed ID: 3159222
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostaglandin therapy in severe limb ischemia.
    Pardy BJ; Eastcott HH
    World J Surg; 1983 May; 7(3):353-62. PubMed ID: 6349140
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug therapy of vasculitis with prostaglandins].
    Makino S
    Nihon Rinsho; 1985 Oct; 43(10):2200-5. PubMed ID: 3912548
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostaglandin I2 and E1 and red cell deformability in raynaud's phenomenon and systemic sclerosis.
    Gaylarde PM
    Br Med J (Clin Res Ed); 1981 Dec; 283(6306):1608-9. PubMed ID: 6796187
    [No Abstract]   [Full Text] [Related]  

  • 7. Raynaud's syndrome: current trends.
    Belch JJ; Sturrock RD
    Br J Rheumatol; 1983 Feb; 22(1):50-5. PubMed ID: 6337664
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemorrheological effects of prostaglandin E1 infusion in Raynaud's syndrome.
    Lucas GS; Simms MH; Caldwell NM; Alexander SJ; Stuart J
    J Clin Pathol; 1984 Aug; 37(8):870-3. PubMed ID: 6540787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2).
    Dowd PM; Martin MF; Cooke ED; Bowcock SA; Jones R; Dieppe PA; Kirby JD
    Br J Dermatol; 1982 Jan; 106(1):81-9. PubMed ID: 7037038
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclic adenine nucleotide levels in lymphocytes from patients with systemic sclerosis: efficiency of prostaglandin infusions.
    Kovacs IB; Dowd PM; Kirby JD; Turner P
    Postgrad Med J; 1983 Apr; 59(690):241-3. PubMed ID: 6306626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of vasospastic disease with prostaglandin E1.
    Cleophas AJ; Fennis JF; van't Laar A
    Br Med J (Clin Res Ed); 1981 May; 282(6274):1476. PubMed ID: 6784876
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of cardiovascular disease with prostaglandins.
    Szczeklik A
    Vasa; 1984; 13(4):360-4. PubMed ID: 6393628
    [No Abstract]   [Full Text] [Related]  

  • 13. Epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome.
    Kahan A; Weber S; Amor B; Menkes CJ
    Lancet; 1983 Mar; 1(8323):538. PubMed ID: 6131248
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulatory uses of prostaglandins.
    Drug Ther Bull; 1984 Dec; 22(26):101-3. PubMed ID: 6394257
    [No Abstract]   [Full Text] [Related]  

  • 15. [New treatments for Raynaud's syndrome].
    Bellucci S; Kedra W; Ajzenberg N; Tobelem G; Caen J
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):103-7. PubMed ID: 3290833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of prostaglandin E1 in rapidly progressive glomerulonephritis.
    Niwa T; Maeda K; Asada H; Yamamoto M; Yamada K
    N Engl J Med; 1983 Apr; 308(16):969. PubMed ID: 6682176
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.
    Martin MF; Dowd PM; Ring EF; Cooke ED; Dieppe PA; Kirby JD
    Ann Rheum Dis; 1981 Aug; 40(4):350-4. PubMed ID: 7259326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus relapse after prostaglandin E(1) administration: activation of a cytokine cascade?
    de la Torre M; Alcázar R; Sánchez de la Nieta D; Nieto J; Ferreras I; Urra JM
    Ann Rheum Dis; 2002 Jan; 61(1):91-2. PubMed ID: 11779776
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vital capillary microscopic examination and transcutaneous pO2-measurements by intravenous prostaglandin E1 infusion].
    Heidrich H; Lammersen T
    Dtsch Med Wochenschr; 1985 Aug; 110(34):1283-5. PubMed ID: 4040847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary results of prostaglandin E1 therapy in peripheral obliterating arteriopathy].
    Pilger E; Juan H
    Wien Klin Wochenschr; 1983 Apr; 95(8):263-6. PubMed ID: 6683910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.